[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
GSK plc (GSK)
GSK plc announced FDA approval for Blujepa (gepotidacin), a new antibiotic for gonorrhea, and received Orphan Drug Designation for risvutatug rezetecan for small-cell lung cancer.
About GSK plc
GSK plc is a multinational pharmaceutical and biotechnology company.
GSK plc uses the ticker $GSK for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- GSK plc (GSK) trading volume is up XXXXX% from the previous week.
- GSK plc (GSK) social dominance is up XXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
GSK's stock price is near a 52-week high, supported by positive sentiment from FDA approvals and social media engagement, but recent legal disputes and concerns over Blenrep's label restrictions may introduce volatility.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XX on 2025-12-03
1-Year Low: $XXXXX on 2025-01-14
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
GSK plc (GSK) is currently AltRank #1,015 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XX
X Month: XXX +384
X Months: XXX -XXX
X Year: XXX +323
1-Year High: XXXXX on 2025-06-19
1-Year Low: X on 2025-02-09
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX +18
1-Year High: XX on 2025-05-13
1-Year Low: XX on 2025-07-03
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +29%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-02-05
1-Year Low: XXX on 2025-12-07
Engagements by network (24h): Reddit: XX X: XXXXX YouTube: X
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +74%
X Year: XXXXX +72%
1-Year High: XXX on 2025-08-03
1-Year Low: XX on 2025-12-07
Mentions by network (24h): Reddit: X X: XXX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning GSK plc (GSK) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +73%
X Year: XXXXX +64%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-12-07
The most influential creators that mention GSK plc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @Capitol_Forum | X | XXXXX | X | XXX |
| @MoneyMaker0009 | X | XXX | X | XX |
| @fastmoneysource | X | XXX | X | XX |
| @tradingfloorai | X | XXXXX | X | XX |
| @Darwin_Knows | X | XXX | X | XX |
| @Quantumup1 | X | XXXXX | X | XX |
| @BioSignal | X | XX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +8%
X Month: XX% +22%
X Months: XX% +14%
X Year: XX% +18%
1-Year High: XXX% on 2025-04-21
1-Year Low: XX% on 2025-08-26
Most Supportive Themes:
- FDA Approval of Blenrep: (30%) GSK's multiple myeloma drug Blenrep has received FDA approval for specific patient groups, marking a significant regulatory milestone.
- Earnings Reports and Financial Performance: (25%) GSK's recent earnings reports and financial performance are being closely watched and discussed, with revenue and EPS figures highlighted.
- Partnerships and Acquisitions: (20%) GSK is actively engaging in strategic partnerships and acquisitions, such as the deal with Empirico, to expand its pipeline and market reach.
Most Critical Themes:
- Blenrep Label Restrictions: (40%) Despite FDA approval, Blenrep's label is narrower than anticipated, raising concerns about its near-term commercial upside and market penetration.
- Pipeline Development Challenges: (35%) GSK faces ongoing challenges in its R&D pipeline, with some drug candidates like the one partnered with Alector failing in late-stage trials.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% +0.0069%
X Month: XXXXXX% -XXXXX%
X Months: XXXXXX% -XXXXXX%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-12-07
Market Dominance: XXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXX% on 2024-12-16
Market Cap: $XXXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX +$0.59%
X Month: $XXXXXXXXXXXXXX +$1.50%
X Months: $XXXXXXXXXXXXXX +$19%
X Year: $XXXXXXXXXXXXXX +$40%
1-Year High: $XXXXXXXXXXXXXX on 2025-12-03
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-14
Top GSK plc Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$PGEN acquisition odds 40-50% in 2026PAPZIMEOS launch + HPV pipeline scream value at $1B mkt cap. Insider buys Tang Capital stake fuel speculation. Likely suitors: $MRK (Gardasil synergy) $GSK (HPV vaccines) $PFE (oncology bolt-on). Q4 earnings could ignite. $PGEN #biotech $PGEN"
X Link @yusufhameed 2025-12-11T18:13Z 1748 followers, XX engagements
"#tradingfloorai #GSK #Approvals Summary: GSK plc announced on December XX 2025 that the U.S. Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea (uGC) in adults and adolescents aged XX and older weighing at least XX kg. This approval marks the first new antibiotic class for gonorrhoea in over three decades offering a much-needed alternative to injectable treatments. Key Highlights: - Innovation: Blujepa is the first new class of antibiotics for gonorrhoea since 1987"
X Link @tradingfloorai 2025-12-11T18:08Z 1928 followers, XXX engagements
"$OODH - Orion Expands Rare Earth and Critical-Mineral Holdings With New Nevada Lease; Provides Update on Multi-State Energy Operations $PG $MRK $MYL $VRTX $BIIB $BMY $JNJ $AZN $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS $WBA $RAD $HLF $CJJD $GNC $DPLO"
X Link @MoneyMaker0009 2025-12-11T16:41Z XXX followers, XXX engagements
"Health Care Weekly: HHS-OIG Audit on IRFs Due Next Month; Imprimis Gets Temporary License Extension in CA; Biden's Nursing Home Staffing Mandate Repealed; Proposed Changes to Kidney Transplant Program; Teva-Corcept Update; New 483s h/t @AliceTrace67285 $AMRX $CDNA $CI $CORT $CVS $EBRO $EHC $ENSG $GSK $HIMS $HROW $HUM $LLY $MPLN $MRK $NHC $NTRA $PACS $PEP $SAN $SNY $TAK $TEVA $UNH $USFD $VTRS"
X Link @Capitol_Forum 2025-12-11T15:41Z 6094 followers, XXX engagements